Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2017-09-04 | 2017-11-20 | 20875 |
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2024-07-18 | 2024-09-20 | 233330 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2025-05-29 | 2025-07-12 | 258824 |
| APO-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2017-08-14 | 2017-12-07 | 19129 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2022-12-09 | 2023-01-31 | 177609 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2020-08-14 | 2020-11-18 | 122276 |
| APO-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2019-08-08 | 2020-06-24 | 91143 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-08-18 | 2023-09-12 | 202406 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183489 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2025-01-30 | 2025-04-11 | 249096 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222470 |
| APO-IBUPROFEN | 200MG | TABLET | Resolved | 2022-02-11 | 2022-05-14 | 154762 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-04-09 | 2021-05-01 | 137250 |
| APO-IBUPROFEN | 200MG | TABLET | Resolved | 2024-03-01 | 2024-03-29 | 221087 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-03-19 | 2021-06-07 | 136019 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180109 |
| APO-IBUPROFEN TAB 200MG | 200MG | TABLET | Resolved | 2019-02-24 | 2020-04-01 | 76717 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210733 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-04-14 | 2023-04-21 | 189638 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2024-01-12 | 2024-03-29 | 215967 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NITRAZEPAM TABLETS BP | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
| APO-NITRAZEPAM TABLETS BP | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-NORTRIPTYLINE - CAP 10MG | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
| APO-NORTRIPTYLINE - CAP 25MG | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
| APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
| APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
| APO-PROPRANOLOL TAB 20MG | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |